Free Trial

Short Interest in Shandong Weigao Group Medical Polymer Company Limited (OTCMKTS:SHWGF) Declines By 98.9%

Shandong Weigao Group Medical Polymer logo with Medical background
Remove Ads

Shandong Weigao Group Medical Polymer Company Limited (OTCMKTS:SHWGF - Get Free Report) was the recipient of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 30,500 shares, a decrease of 98.9% from the February 13th total of 2,772,900 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days. Currently, 0.0% of the shares of the company are sold short.

Shandong Weigao Group Medical Polymer Trading Up 0.2 %

Shandong Weigao Group Medical Polymer stock traded up $0.00 during mid-day trading on Wednesday, reaching $0.66. The stock has a 50 day moving average of $0.66 and a 200-day moving average of $0.76. Shandong Weigao Group Medical Polymer has a fifty-two week low of $0.65 and a fifty-two week high of $0.67. The company has a current ratio of 3.28, a quick ratio of 2.89 and a debt-to-equity ratio of 0.14.

Shandong Weigao Group Medical Polymer Company Profile

(Get Free Report)

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Shandong Weigao Group Medical Polymer Right Now?

Before you consider Shandong Weigao Group Medical Polymer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shandong Weigao Group Medical Polymer wasn't on the list.

While Shandong Weigao Group Medical Polymer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads